Literature DB >> 1110435

Patent ductus arteriosus complicating respiratory distress syndrome.

W A Neal, F B Bessinger, C E Hunt, R V Lucas.   

Abstract

PDA was diagnosed in 76 (19%) of 396 patients with RDS. Evidence of excessive pulmonary blood flow and CHF developed in 15 (20%). CHF was not recognized prior to 10 days of age in any patient. All 15 with CHF were initially managed medically. Seven improved; three died of other causes. Five patients who failed medical management were surgically treated; all survived operation, but only two were improved.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110435     DOI: 10.1016/s0022-3476(75)80723-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Clues in diagnosing congenital heart disease.

Authors:  A J Moss
Journal:  West J Med       Date:  1992-04

2.  Conservative management of patent ductus arteriosus in preterm infants.

Authors:  M C Lelong Tissier; A Benoit; M Dehan; M Vial; J C Ropert; Y Dupic
Journal:  Intensive Care Med       Date:  1979-03       Impact factor: 17.440

3.  Management of premature infants with patent ductus arteriosus.

Authors:  T A Merritt; L Gluck; C Higgins; W Friedman; W L Nyhan
Journal:  West J Med       Date:  1978-03

4.  Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.

Authors:  H H Ivey; J Kattwinkel; T S Park; L J Krovetz
Journal:  Br Heart J       Date:  1979-03

5.  Persistent ductus arteriosus complicating the respiratory distress syndrome.

Authors:  R W Jones; D Pickering
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

6.  Ligation of patent ductus arteriosus in the very low birthweight newborn infant.

Authors:  R W Cooke; B Gribbin; A J Gunning; D Pickering
Journal:  Arch Dis Child       Date:  1978-04       Impact factor: 3.791

7.  Patent ductus arteriosus in premature infants: a review of current management.

Authors:  W A Neal; M D Mullett
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.